Exercise, Arterial Modulation and Nutrition in Youth South Africa Study (ExAMIN-Youth)

January 31, 2024 updated by: Ruan Kruger, North-West University, South Africa

The Exercise, Arterial Modulation and Nutrition in Youth South Africa (ExAMIN Youth SA) Study

The ExAMIN Youth SA study aims to generate new knowledge on the pathophysiology involved in early vascular aging among South African children and to identify early novel biological markers for predicting the subclinical development of hypertension and target organ damage related to cardiovascular disease. This study further implements state-of-the-art biochemical technology to measure a variety of biological markers including multiplex analyses and metabolomics. With the increasing prevalence of childhood hypertension and obesity, this study will be able to address especially behavioural contributors to hypertension development and to subsequently provide a backdrop for school-based primary prevention interventions.

Study Overview

Status

Active, not recruiting

Detailed Description

Background: The current global widespread incidence of obesity and early cardiovascular deterioration are two of the most important future health care challenges. Physical inactivity and its associated unhealthy dietary intake among adolescents are of great concern, especially in a South African setting in which no current monitoring occurs to describe the impact of this sedentary and unhealthy lifestyle on cardiovascular health. With the estimated global prevalence of elevated blood pressure among children between 12-25%, there is a definite need to contribute to the lack of population level data in South Africa and how lifestyle behaviours impact on the burden of non-communicable disease.

Main aim: Our current study aims to build on previous findings to identify potential contributing factors that may adversely affect health outcomes in South African children. Additionally, we will cross-compare data with international centres on these health outcomes, and finally develop predictive models on target organ damage at 4-years follow-up from baseline data.

Design/Methods: We phenotyped a cohort of 1065 primary school children (all sexes, all ethnic groups and ages 5-9 years) according to their physical fitness and coordination, their dietary behaviours, psychosocial behaviour and current cardiovascular state. Parents of participating children provided information on socio-demographics including data on education, employment, types of dwelling, household amenities and parents' marital status, health habits, and lifestyle. The children will underwent the following measurements: anthropometric measurements of height, weight, waist circumference, triceps and subscapular skinfolds; stable isotope and bioelectric impedance analysis to measure body composition; blood pressure along with pulse wave analysis and aortic pulse wave velocity, static retinal vessel analysis (without mydriasis); accelerometry and a standardised physical activity questionnaire to measure physical activity. Physical fitness measures included motor skills, coordination, flexibility and cardio-respiratory fitness. Urinalysis will include creatinine, albumin, electrolytes, nitrates, nitrites, dimethylarginines, malondialdehyde, glucose, cardiovascular and kidney multiplex panels, and targeted metabolomics. Salivary analyses will include sex hormones and cortisol.

Outcomes: The primary outcomes for the baseline analysis include blood pressure, pulse wave velocity and retinal vascular calibres to address micro- and macrovascular compromise in relation to behavioural risk factors. In the follow-up phase of the study we will include carotid intima media thickness and left ventricular mass as outcomes of baseline predictors.

Timetable: The project was approved and is endorsed by the District Director of the Department of Education, and was approved by the Health Research Ethics Committee of the North-West University on 10 may 2017 (NWU-00091-16-A1). Data collection started in September 2017 and baseline measurements were concluded on 30 April 2019. Follow-up assessments will commence immediately in subsequent years for the 4-year follow-up phase of the study.

Study Type

Observational

Enrollment (Actual)

1065

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • North West
      • Potchefstroom, North West, South Africa, 2531
        • Hypertension in Africa Research Team (HART), North-West University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 10 years (Child)

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population included 1103 children (at baseline) attending public primary schools in the Dr Kenneth Kaunda district, North West province, South Africa aged between 5 and 9 years of age. However, with a few missing (n=38) values of basic variables of interest such as sex, ethnicity or date of birth, we included a total 1065 children (mean age=7.44 years or 89.3 months). The majority of the participants were of African (n=579) and white (n=463) ethnicity, whereas only 2.2% (n=23) participants were of either Indian or mixed race. The sex distribution was similar in the white group, whereas the study unintentionally included more girls (58.5%) than boys (41.5%) in the black group.

Description

Inclusion Criteria:

  • Children between ages 5 and 9 years (both sexes and all ethnicities).

Exclusion Criteria:

  • Children who do not wish to participate or where the parents or caregivers did not provide permission.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Black boys
240 black boys were included in the study (mean age 7.5 years)
Black girls
339 black girls were included in the study (mean age 7.5 years)
White boys
239 white boys were included in the study (mean age 7.4 years)
White girls
224 white girls were included in the study (mean age 7.4 years)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To determine blood pressure classification among primary school children in South Africa
Time Frame: Through study completion, an average of 1 year
Elevated blood pressure and stage 1 hypertension according to the American Academy of Pediatrics Clinical Practice Guidelines 2017 stratified for age, sex, weight and height. Automated oscillometric calculations of central systolic blood pressure and pulse wave velocity.
Through study completion, an average of 1 year
To determine overweight and obesity prevalence among primary school children in South Africa
Time Frame: Through study completion, an average of 1 year
Overweight and obesity classification according to the World Health Organisation percentiles for childhood obesity
Through study completion, an average of 1 year
To identify novel biomarkers in predicting elevated blood pressure in primary school children from South Africa
Time Frame: Through study completion, an average of 1 year
Multiplex analysis of cardiovascular and kidney related biomarkers, and subsequently metabolomics and hormone concentrations
Through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Associations of central blood pressure and aortic stiffness with physical fitness
Time Frame: Through study completion, an average of 1 year
Physical fitness (cardiorespiratory fitness, coordination, endurance, speed, balance) and activity (accelerometry)
Through study completion, an average of 1 year
Associations of central blood pressure and aortic stiffness with body composition
Time Frame: Through study completion, an average of 1 year
Anthropometry including body heigh, body weight, waist-to-height ratio, and body fat percentage
Through study completion, an average of 1 year
Associations of central blood pressure and aortic stiffness and dietary intake
Time Frame: Through study completion, an average of 1 year
Healthy and unhealthy food consumption frequencies determined by validate survey to depict unhealthy and healthy food group patterns
Through study completion, an average of 1 year
Associations of central blood pressure and aortic stiffness and childhood adversity
Time Frame: Through study completion, an average of 1 year
Early life stress events as quantified by validated psychosocial questionnaires.
Through study completion, an average of 1 year

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determine the change in blood pressure over a 4-year follow-up period in primary school children of South Africa
Time Frame: Through study completion, 4 years after baseline measurements
Automated oscillometric calculations of central systolic blood pressure and pulse wave velocity at baseline and 4-years follow-up
Through study completion, 4 years after baseline measurements
Determine baseline predictors of target organ damage markers after a 4-year follow-up period in primary school children of South Africa
Time Frame: Through study completion, 4 years after baseline measurements
Target organ damage will be assessed at follow-up by carotid intima media thickness and left ventricular mass.
Through study completion, 4 years after baseline measurements

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 12, 2017

Primary Completion (Actual)

April 30, 2019

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

August 12, 2019

First Submitted That Met QC Criteria

August 12, 2019

First Posted (Actual)

August 14, 2019

Study Record Updates

Last Update Posted (Actual)

February 1, 2024

Last Update Submitted That Met QC Criteria

January 31, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

3
Subscribe